FIB is an acute contrast-protein synthesized by the liver and elevated concentration is an important risk factor for thrombosis and cardiovascular disease. FIB test is a routine test for bleeding and thrombosis

Activated coagulation time ACT can be used to monitor the anticoagulability of heparin, which is of great significance for monitoring the clinical use of heparin. Sometimes the test is used in conjunction with the PT test to determine whether bleeding is due to an excess of anticoagulants or to clotting factor depletion.

TT is a simple test for detect of coagulation detection, anticoagulation and fibrin deliquescent system function. It is widely used in monitoring and treating high molecular weight heparin and fibrinolytic, screening fibrinogen disorders and some serious fibrinogen deficiency, which is of great significance to disease diagnosis of clinical departments.

APTT is a sensitive and commonly used screening test for endogenous clotting systems, which can also be used as quantitative test of endogenous coagulation factors to detect serum factors other than VII, especially for the test of factor VIII, IX, XI, XII and prekallikrein. Besides, APTT test can be used for monitoring heparin treatment.

PT test is a fairly ideal and commonly used screening test for extrinsic pathway of blood clotting. It can also be used as quantitative test for exogenous pathways and common pathways of coagulation factors. At the same time, it can be used for monitoring oral anticoagulant therapy.